Showing results (541-550 of 692) with videos related to
Sort By:
Pageof 70
Investigational New Drugs|January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomasJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.International Journal of Molecular Sciences|November 9, 2024
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAntYangmei Li, William E Cotham, Abbe Eliasof, et al.Leukemia & Lymphoma|June 1, 1995
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinaseS Suki, F Swan, S Tucker, et al.Leukemia & Lymphoma|June 1, 1997
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphomaA Younes, M A Rodriguez, P McLaughlin, et al.Cancer|May 1, 1994
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysisW S Velasquez, P McLaughlin, L M Fuller, et al.Irish Journal of Medical Science|January 25, 2022
Breast cancer recurrence: factors impacting occurrence and survivalDonald Courtney, Matthew G Davey, Brian M Moloney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III diseaseT M Lopez, F B Hagemeister, P McLaughlin, et al.Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic PainRyosuke Shinouchi, Bengisu Turgutalp, Rohini S Ople, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioidsW Xie, G M Samoriski, J P McLaughlin, et al.AIDS (London, England)|February 1, 1997
Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New EnglandR J MacGowan, R M Brackbill, D L Rugg, et al.Pageof 70